| Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, ... Journal of Clinical Oncology 26 (32), 5233, 2008 | 1641 | 2008 |
| Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer N Zacharakis, H Chinnasamy, M Black, H Xu, YC Lu, Z Zheng, A Pasetto, ... Nature medicine 24 (6), 724-730, 2018 | 775 | 2018 |
| Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade SG Downey, JA Klapper, FO Smith, JC Yang, RM Sherry, RE Royal, ... Clinical Cancer Research 13 (22), 6681-6688, 2007 | 747 | 2007 |
| Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels JN Kochenderfer, RPT Somerville, T Lu, V Shi, A Bot, J Rossi, A Xue, ... Journal of Clinical Oncology 35 (16), 1803, 2017 | 546 | 2017 |
| High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the … JA Klapper, SG Downey, FO Smith, JC Yang, MS Hughes, US Kammula, ... Cancer 113 (2), 293-301, 2008 | 493 | 2008 |
| Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma SL Goff, ME Dudley, DE Citrin, RP Somerville, JR Wunderlich, ... Journal of Clinical Oncology 34 (20), 2389, 2016 | 412 | 2016 |
| Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer S Krishna, FJ Lowery, AR Copeland, E Bahadiroglu, R Mukherjee, L Jia, ... Science 370 (6522), 1328-1334, 2020 | 329 | 2020 |
| Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines FO Smith, SG Downey, JA Klapper, JC Yang, RM Sherry, RE Royal, ... Clinical Cancer Research 14 (17), 5610-5618, 2008 | 314 | 2008 |
| Pilot trial of adoptive transfer of chimeric antigen receptor transduced T cells targeting EGFRvIII in patients with glioblastoma SL Goff, RA Morgan, JC Yang, RM Sherry, PF Robbins, NP Restifo, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 42 (4), 126, 2019 | 279 | 2019 |
| Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study SS Chandran, RPT Somerville, JC Yang, RM Sherry, CA Klebanoff, ... The Lancet Oncology 18 (6), 792-802, 2017 | 271 | 2017 |
| mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer G Cafri, JJ Gartner, T Zaks, K Hopson, N Levin, BC Paria, MR Parkhurst, ... The Journal of clinical investigation 130 (11), 5976-5988, 2020 | 269 | 2020 |
| Treatment of patients with metastatic cancer using a major histocompatibility complex class II–restricted T-cell receptor targeting the cancer germline antigen MAGE-A3 YC Lu, LL Parker, T Lu, Z Zheng, MA Toomey, DE White, X Yao, YF Li, ... Journal of Clinical Oncology 35 (29), 3322, 2017 | 248 | 2017 |
| Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers MR Parkhurst, PF Robbins, E Tran, TD Prickett, JJ Gartner, L Jia, G Ivey, ... Cancer discovery 9 (8), 1022-1035, 2019 | 204 | 2019 |
| Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers FJ Lowery, S Krishna, R Yossef, NB Parikh, PD Chatani, N Zacharakis, ... Science 375 (6583), 877-884, 2022 | 199 | 2022 |
| Long-term follow-up of anti-CD19 chimeric antigen receptor T-cell therapy KM Cappell, RM Sherry, JC Yang, SL Goff, DA Vanasse, L McIntyre, ... Journal of Clinical Oncology 38 (32), 3805, 2020 | 179 | 2020 |
| Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2 B Heemskerk, K Liu, ME Dudley, LA Johnson, A Kaiser, S Downey, ... Human gene therapy 19 (5), 496-510, 2008 | 178 | 2008 |
| Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL SL Goff, FO Smith, JA Klapper, R Sherry, JR Wunderlich, SM Steinberg, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (8), 840, 2010 | 163 | 2010 |
| The role of immune cells in breast tissue and immunotherapy for the treatment of breast cancer SL Goff, DN Danforth Clinical Breast Cancer 21 (1), e63-e73, 2021 | 124 | 2021 |
| Adoptive cell therapy—tumor-infiltrating lymphocytes, T-cell receptors, and chimeric antigen receptors SA Feldman, Y Assadipour, I Kriley, SL Goff, SA Rosenberg Seminars in oncology 42 (4), 626, 2015 | 102 | 2015 |
| Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression JA Wargo, PF Robbins, Y Li, Y Zhao, M El-Gamil, D Caragacianu, ... Cancer immunology, immunotherapy 58, 383-394, 2009 | 97 | 2009 |
Steven A RosenbergNCIVerified email at nih.gov
